Which of the statements is FALSE regarding acute fatty liver of pregnancy?
AFLP is a rare but serious condition occurring in late pregnancy, usually the third trimester. It's characterized by microvesicular steatosis in the liver. The mainstay of treatment is delivery, as that's the only effective treatment. The condition can lead to multiorgan failure if not managed promptly.
The question is asking which statement is FALSE. Let's think about common misconceptions or incorrect statements about AFLP. For example, some might confuse it with HELLP syndrome or preeclampsia. Also, certain lab findings like elevated liver enzymes, coagulopathy, and hypoglycemia are typical.
Possible wrong options could include statements like "AFLP occurs most commonly in the first trimester" (which is false because it's third trimester), or "AFLP is caused by a deficiency of peroxisomal oxidation enzymes in the fetus" (which is actually true, related to FAH deficiency). Another incorrect statement might be that "AFLP is associated with normal liver enzymes" (false because enzymes are elevated). Also, maybe "AFLP is managed with corticosteroids" (incorrect, as delivery is the treatment).
Now, the correct answer (the false statement) would be one of these. Let's structure the explanation. The core concept is AFLP's presentation, pathophysiology, and management. The correct answer is the false one, so I need to detail why it's wrong. Each incorrect option should be addressed with why they're correct or incorrect. The clinical pearl would highlight the critical point that delivery is the main treatment and the importance of timely intervention.
**Core Concept**
Acute fatty liver of pregnancy (AFLP) is a rare, life-threatening disorder of late pregnancy caused by a genetic defect in fatty acid oxidation in the fetal liver. It presents with microvesicular hepatic steatosis, coagulopathy, and multiorgan dysfunction. Prompt delivery is the definitive treatment.
**Why the Correct Answer is Right**
The false statement is **Option C**: "AFLP is most commonly diagnosed in the first trimester." AFLP typically occurs in the **third trimester** (after 28 weeks) or during the postpartum period. Its pathogenesis is linked to maternal-fetal transfer of a defective peroxisomal enzyme (acyl-CoA oxidase 1), leading to fatty acid accumulation in maternal hepatocytes. Early diagnosis and delivery are critical to prevent maternal and fetal mortality.
**Why Each Wrong Option is Incorrect**
**Option A:** "AFLP is associated with elevated serum transaminases" – Correct. Severe hepatocellular injury causes marked AST/ALT elevation.
**Option B:** "AFLP is managed with immediate delivery" – Correct. Delivery resolves the condition in nearly all cases.
**Option D:** "AFLP is linked to a defect in peroxisomal beta-oxidation" – Correct. Fetal inheritance of a mutation in the *ACADVL* or *ACY1* gene is implicated.
**Clinical Pearl / High-Yield Fact**
Remember **"AFLP = fatty